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Abstract
Legionella pneumophila is a gram-negative pathogen that causes a severe pneumonia known as Legionnaires’ disease. Here,
we demonstrate for the first time that L. pneumophila infects and grows within cultured human endothelial cells. Endothelial
infection may contribute to lung damage observed during Legionnaires’ disease and to systemic spread of this organism.
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Introduction
Legionella pneumophila causes an estimated 2–15% of community
acquired pneumonia requiring hospitalization [1]. L. pneumophila is
a gram-negative pathogen whose primary ecological niche appears
to be as a parasite of protozoa. However, humans and other
animals may become secondarily infected after inhaling or
aspirating organisms.
Fascinatingly,thecellbiologyofinfection ofprotozoaand humans
cells appears remarkably similar. On entering both macrophages [2]
and protozoa [3,4], L. pneumophila inhibits phagolysosome fusion [5]
and multiplies in a compartment having properties of endoplasmic
reticulum [6]. Escape from phagolysosome fusion, intracellular
multiplication, and lysis of the host cell relies on a type IV secretion
system encoded by the dot/icm gene complex [7–9].
Resident alveolar macrophages appear to be a Trojan horse for
human infection [10]. L. pneumophila infects these cells and
continues to grow within macrophages recruited during the
subsequent inflammatory response. Infection may then spread to
alveolar epithelial cells that line the airways, supported by
observations of growth in primary [11] and transformed type I
[12] and II pneumocytes [13], and growth of the related L. dumoffii
in alveolar epithelial cells in vivo [14].
Bacterial dissemination does not stop at the alveolar wall. In both
human autopsy studies [15] and animal models [16], L. pneumophila
spreads to multiple organs. This suggests that the organism may
infect and breach the remaining anatomic barrier in the lung —
pulmonary blood vessels — as a potential initiating event in systemic
spread of the organism via the blood stream. Here, we begin to
address this hypothesis through in vitro study of the interaction of
Legionella pneumophila with primary human endothelial cells.
Results
Infection of endothelial cells
We first tested whether Legionella pneumophila strain Lp01 [17]
invades into primary human umbilical vein endothelial cells
(HUVEC). Using a gentamicin protection assay, we assessed
whether bacteria were protected from gentamicin [18], a polar
antibiotic that penetrates slowly into eukaryotic cells and does not
kill internalized bacteria during the time frame of the assay. Using
this procedure, we found that L. pneumophila, strain Lp01,
reproducibly invades into endothelial cells (see Fig. 1) with
approximately 0.05% of bacteria internalized during a 2 hour
incubation. The ability of L. pneumophila to invade into endothelial
cells was confirmed by fluorescent microscopy where internalized
bacteria were distinguished by differential staining as described in
detail below.
Of note, the invasion efficiency was roughly 100 fold lower than
what was previously observed for primary macrophages [19], an
expected result since endothelial cells are not professional
phagocytes. We compared invasion efficiency to the L. pneumophila,
isogenic dotI mutant, HL051C [20], which was previously shown
to be defective in inhibition of phagolysosome fusion and
intracellular replication in macrophages. Although a trend towards
slightly lower invasion efficiency by HL051C was noted, this did
not reach statistical significance (Fig. 1). Previously, invasion of a
dot/icm mutant, but not wild type L. pneumophila was shown to be
blocked by the PI-3 kinase inhibitor, wortmannin [21], implying
that invasion of wild type and mutant bacteria occur through
distinct pathways. We found the same to be true in endothelial
cells (Fig. 1). Here, treatment with 100 nM wortmannin led to a
4.5 fold reduction in invasion of HL051C (P=0.005) vs. an
insignificant reduction of 1.5 fold for Lp01. Therefore, since
wortmannin did not substantially block invasion of wild type
bacteria, invasion of wild type and the dotI mutant appears to
occur by distinct pathways as described previously for macro-
phages [21,22].
Replication of bacteria within endothelial cells
We next tested whether L. pneumophila replicates inside of
endothelial cells. As shown in Fig. 2, we found that wild type Lp01
replicates to high levels in HUVEC with a two to three log growth
increase, leading to lysis of host cells and release of bacteria (data not
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was gradually eliminated. These results are consistent with previous
observations in macrophages and suggest that growth is dependent
on the dot/icm-dependent, type IV secretion system [17,23]. These
observations were confirmed by fluorescent microscopy where large
numbers of Lp01 were found intracellularly at later time points vs.
the infrequent appearance of HL051C. The latter often appeared to
have degraded nucleoids by DAPI staining.
Similar growth curves were observed for other endothelial cell
types tested including primary human lung microvascular and
umbilical artery endothelial cells (data not shown). The ability to
grow in the diverse types of endothelial cells surveyed is especially
interesting as they are known to have diverse physiological
properties [24]. Bacteria also grew within primary pulmonary
artery endothelial cells of bovine origin (a species that also
develops Legionnaires’ disease [25]), suggesting that the ability to
infect endothelial cells crosses species boundaries.
Altered phagosome properties
We next examined whether L. pneumophila inhibits fusion of
bacterial phagosomes with lysosomes, as observed previously
during infection of macrophages[5]. Using an immunofluores-
cence staining technique, we assessed the colocalization of
internalized bacteria with a lysosomal marker, LAMP-1. At
1.5 hours after infection, only 6% of Lp01 colocalized with
LAMP-1 vs. 57% of the dotI mutant (P,0.001, Fig. 3). Therefore,
only the replication-competent Lp01, but not the replication-
defective dotI mutant, efficiently escaped from lysosomal fusion.
We next examined the morphogenesis of L. pneumophila
containing vacuoles by transmission electron microscopy. Within
6 hours of infection by Lp01, most bacterial phagosomes were
surrounded by ribosome studded endoplasmic reticulum (RER)
(Fig. 4A,B), as observed previously in infected macrophages [26]
and amoeba [27]. At 24 hours after infection, organisms had
multiplied in vacuoles to largely fill the endothelial cell (Fig. 4C).
In contrast, the dotI mutant was always contained in smooth
vacuoles, usually as single bacteria, and without associated RER or
ribosomes at all time points (Fig. 4D, E). Furthermore, mutant
bacteria often appeared degraded and were occasionally found in
vacuoles containing membranous debris (Fig. 4F). Both mutant
and wild type organisms were found in membrane-bound
phagosomes, never freely in the cytoplasm, although disruption
of the vacuolar membrane was noted late in the infection cycle of
wild type organisms. Taken together, intracellular parasitism of
endothelial cells appears similar to observations in macrophages.
Discussion
Here, we for the first time identify the ability of Legionella
pneumophila to invade and replicate inside diverse types of primary
human endothelial cells, including endothelial cells obtained from
the lung. We believe that this property may have special relevance
for the pathogenesis of Legionnaires’ disease. Previous studies have
focused on the organism’s ability to grow within macrophages and
alveolar epithelial cells. However, the capillary network, formed by
endothelial cells, also makes up a critical and potentially
vulnerable part of the lung.
The biology of endothelial infection is consistent with what has
been described for infection of macrophages, alveolar epithelial
cells, and protozoa. The organism inhibits phagolysosome fusion
and grows intracellularly in a process dependent on the dot/icm
type IV secretion machinery. However, contact-dependent
cytotoxicity observed during infection of macrophages and red
blood cells [19,28] does not occur (i.e., as determined by LDH
release assay[19] after pelleting bacteria onto an endothelial
monolayer for 5 minutes at 800 g, data not shown). This may
reflect a greater resistance to osmotic lysis, differences in the
interaction with the bacterial type IV secretion machinery, or
decreased invasion efficiency. Nevertheless, endothelial cell death
still occurs after intracellular multiplication of bacteria. It is
possible that endothelial cell infection and death in vivo leads to
damage of pulmonary capillaries and allows bacteria access to the
Figure 1. Legionella pneumophila invades into endothelial cells.
L. pneumophila strains Lp01 (wt) and an isogenic dotI mutant were
seeded onto HUVEC at a ratio of approximately 300:1. After a two hour
incubation in the presence or absence of 100 nM wortmannin,
gentamicin treatment was used to kill extracellular bacteria, and then
intracellular bacteria were enumerated. Intracellular bacteria are
expressed as percentage of the original titered inoculum to determine
the invasion efficiency. Results shown are the mean and standard
deviation of sextuplicate assays and are representative of two
independent experiments.
doi:10.1371/journal.pone.0002012.g001
Figure 2. L. pneumophila grows inside of primary human
endothelial cells. Growth curves of L. pneumophila Lp01 (wt) and
an isogenic dotI mutant after infection of HUVEC. At indicated time
points after infection, the numbers of intracellular and extracellular
bacterial colony forming units (cfu) were determined and added
together. As bacteria do not multiply extracellularly, the total number of
bacteria reflects intracellular growth. Data points are the mean and
standard deviation of three separate assays.
doi:10.1371/journal.pone.0002012.g002
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organisms might also contribute to systemic spread.
Endothelial damage may also in part account for pathologies
such as hemorrhage that have been observed during Legionnaires’
disease [29,30] or adverse sequelae such as pulmonary fibrosis
[31]. Here, the lung forms scar tissue rather than re-establishing
surfaces capable of air exchange, leading to permanent disability
after bacteriological cure [31]. Interestingly, patients with
prosthetic heart valves appear to be at particular risk of developing
endocarditis from Legionella [32–34]. Possibly, this relates to a
susceptibility of endothelial cells overlying prosthetic material to
infection with this organism.
Clearly, the extent and consequences of endothelial infection by
L. pneumophila need to be examined using in vivo models. However,
the vascular endothelium should now be considered a potential
participant in the pathogenesis of Legionnaires’ disease.
Materials and Methods
Bacterial strains and infections
Legionella pneumophila strains were described previously [17].
Endothelial cells were purchased from Cambrex and passaged in
EGM2-MV medium from the same manufacturer. To perform
infections, bacteria were grow in AYE medium to early stationary
phase, resuspended in EGM-2MV, and used to infect endothelial
cells grown on collagen I (Vitrogen, Cohesion, Inc.) treated
twenty-four well dishes.
Assessment of bacterial invasion
After infection at a bacterial to endothelial cell ratio of
approximately 300:1, extracellular bacteria were killed by a
45 minute treatment with 100 mg/ml of gentamicin, and surviving
intracellular bacteria enumerated after eukaryotic cell lysis with
0.1% saponin. Statistical comparisons were performed using JMP
IN Vs. 5.1.2 (SAS Institute, Cary, NC) by the Wilcoxon Ranked
Sum Test for continuous and Fisher’s Exact Test for categorical
variables with P,0.05 considered significant.
Assessment of bacterial replication
At multiple time points after infection, both extracellular and
intracellular bacteria were enumerated by sampling extracellular
medium and then intracellular compartments after saponin lysis.
For bacterial replication experiments only, the infectious inoculum
was harvested from aBCYE plates rather than from early
stationary phase liquid cultures used for all other assays.
Endocytic trafficking assay
To assess fusion of L. pneumophila containing phagosomes with
lysosomes, endothelial cells were plated on collagen I-treated,
German glass coverslips (Bellco Glass) and infected at a ratio of
approximately 300 bacteria per endothelial cell. Extracellular
bacteria were stained prior to permeabilization with a rabbit
anti-Legionella primary antibody (gift of Ralph Isberg, Tufts
Medical School) followed by a Alexa-594-labeled goat anti-rabbit
secondary antibody. After permeabilization with 0.2% TritonH-X
100 for 15 minutes, lysosomal compartments were stained with
anti-LAMP-1 mouse monoclonal antibody (Santa Cruz Biotech-
nology, clone H5G11) [35] followed by Alexa-488-labeled goat
anti-mouse secondary antibody (Molecular Probes). Bacterial
nucleoids were then stained with 49,6-diamidino-2-phenylindole
(DAPI). Intracellular bacteria were identified by the absence of
extracellular antibody staining and positive staining with DAPI.




+) was assessed and quantified using a Nikon
Eclipse E300 epifluorescence microscope and images capture
using a Retiga 2000RV digital camera (QImaging, Surrey,
British Columbia) and IPLab software 3.9.4r5 (BD Biosciences,
Rockville, MD)
Figure 3. L. pneumophila inhibits endothelial phagolysosome fusion. Representative images showing lysosomal targeting of bacteria
1.5 hours after infection of HUVEC at a bacterial to endothelial cell ratio of approximately 300:1. The dotI mutant strain, but not Lp01 (wt), show
extensive colocalization with LAMP-1, a lysosomal marker (bacteria stained blue with DAPI, LAMP-1 stained green). An example of a colocalizing
bacteria is indicated with an arrow. Extracellular bacteria (not present in these images) were distinguished by immuno-labeling with a red
fluorophore prior to permeabilization of endothelial cells.
doi:10.1371/journal.pone.0002012.g003
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Bacteria at a multiplicity of infection of approximately 1000:1
were centrifuged onto HUVEC monolayers at 580 g for five
minutes. After incubation for the indicated time points, monolay-
ers were washed with PBS, fixed for twenty minutes in Trump’s
fixative containing 4% formaldehyde and 1% glutaraldehyde,
washed in 0.1 M cacodylate buffer, and post fixed in 1% OsO4.
Monolayers were then washed in maleate buffer, incubated with
uranyl acetate, washed again in maleate buffer, dehydrated in
ascending alcohol washes, embedded as monolayers in Eponate
Figure 4. L. pneumophila replicates in membrane bound compartment associated with endoplasmic reticulum. (A, B) The Lp01strain is
surroundedbyribosomestuddedendoplasmicreticulum(RER) at 6 hours afterinfection.(C)At24 hours,manyphagosomes arefilledwithlargenumbers
of bacteria. In this image, RER association is still evident (left side of vacuole), however, at this late stage in infection, vacuolar membrane appears partially
disrupted. In contrast, dotI mutants do not associate with RER and are surrounded by a simple, smooth membrane, at times also containing membranous
debris, e.g., (D) 6 hours and (E) 24 hours. Intact bacteria were far less numerous, while electron dense structures suggestive of partially degraded bacteria
were often present, (F) 6 hours. Magnifications (in figure): A,654,000; B, 654,000; C 619,000; D 682,000; E 6119,000; F 641,000.
doi:10.1371/journal.pone.0002012.g004
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and sectioned en face. Sections were stained with lead citrate and
viewed with the digital image acquisition system on the Jeol
(Tokyo, Japan) MEM-1011, transmission electron microscope.
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